Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nature's Sunshine Products, Inc. - Common Stock (NQ:NATR)

16.54 -0.04 (-0.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Nature's Sunshine Products, Inc. - Common Stock

< Previous 1 2 3 Next >
NATR Q2 Deep Dive: Digital Expansion and Product Pipeline Drive Upbeat Outlook
Wellness products company Nature’s Sunshine (NASDAQ:NATR) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $114.8 million. The company’s full-year revenue... 
Via StockStory
Nature's Sunshine (NATR) Q2 EPS Up 400%
Via The Motley Fool
Why Nature's Sunshine (NATR) Stock Is Up Today
Shares of wellness products company Nature’s Sunshine (NASDAQ:NATR) jumped 11.9% in the morning session after the company reported strong second-quarter results that beat analyst expectations and... 
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For July 31, 2025
 
Via Benzinga
Earnings Scheduled For May 6, 2025
 
Via Benzinga
Nature's Sunshine (NASDAQ:NATR) Posts Better-Than-Expected Sales In Q2, Full-Year Sales Guidance is Optimistic
Wellness products company Nature’s Sunshine (NASDAQ:NATR) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 3.8% year on year to $114.8 million. The company’s... 
Via StockStory
Nature’s Sunshine Products Inc. (NASDAQ:NATR) Reports Mixed Q2 2025 Earnings: Revenue Miss, EPS Beat
Nature’s Sunshine Products (NATR) reported mixed Q2 2025 results, missing revenue estimates at $114.75M but beating EPS at $0.35. Stock shows neutral reaction amid broader declines. 
Via Chartmill
Nature's Sunshine (NATR) To Report Earnings Tomorrow: Here Is What To Expect
Wellness products company Nature’s Sunshine (NASDAQ:NATR) will be reporting results this Thursday afternoon. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Why Nature's Sunshine (NATR) Shares Are Getting Obliterated Today
Shares of wellness products company Nature’s Sunshine (NASDAQ:NATR) fell 8.5% in the afternoon session after the company announced the pricing of a secondary stock offering by a major shareholder. The... 
Via StockStory
1 Cash-Producing Stock with Solid Fundamentals and 2 to Avoid
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
1 Safe-and-Steady Stock with Exciting Potential and 2 to Question
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Why Nature's Sunshine (NATR) Shares Are Falling Today
Shares of wellness products company Nature’s Sunshine (NASDAQ:NATR) fell 7.2% in the morning session after CEO Terrence Moorehead, announced his decision to step down from his role. The board also... 
Via StockStory
Topics Artificial Intelligence
3 Inflated Stocks in Hot Water
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to new product launches, positive news, or even a dedicated social media... 
Via StockStory
NATR Q1 Earnings Call: Outperformance Driven by Asia-Pacific and Europe Amid Tariff Uncertainty
Wellness products company Nature’s Sunshine (NASDAQ:NATR) announced better-than-expected revenue in Q1 CY2025, with sales up 2% year on year to $113.2 million. The company expects the full year’s... 
Via StockStory
Topics Economy World Trade
3 Consumer Stocks with Mounting Challenges
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. Surprisingly, the sector hasn’t played its shielding role over the past six months as it tumbled 10.5%. This... 
Via StockStory
Topics Stocks
Q1 Earnings Outperformers: Nature's Sunshine (NASDAQ:NATR) And The Rest Of The Personal Care Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at personal care stocks, starting with... 
Via StockStory
Topics Economy
1 of Wall Street’s Favorite Stock to Keep an Eye On and 2 to Be Wary Of
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Nature's Sunshine (NASDAQ:NATR) Beats Q1 Sales Targets
Wellness products company Nature’s Sunshine (NASDAQ:NATR) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2% year on year to $113.2 million. The company expects the... 
Via StockStory
Nature's Sunshine (NATR) Reports Q1: Everything You Need To Know Ahead Of Earnings
Wellness products company Nature’s Sunshine (NASDAQ:NATR) will be announcing earnings results tomorrow after market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
3 Cash-Heavy Stocks in the Doghouse
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining... 
Via StockStory
Winners And Losers Of Q4: Nature's Sunshine (NASDAQ:NATR) Vs The Rest Of The Personal Care Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the personal care stocks, including Nature's Sunshine (NASDAQ:NATR) and its peers. 
Via StockStory
Topics Economy
Personal Care Stocks Q4 Results: Benchmarking Medifast (NYSE:MED)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at personal care stocks, starting with... 
Via StockStory
Topics Economy
3 Reasons to Sell NATR and 1 Stock to Buy Instead
Although the S&P 500 is down 1.6% over the past six months, Nature's Sunshine’s stock price has fallen further to $11.31, losing shareholders 14.1% of their capital. This was partly due to its softer... 
Via StockStory
Topics Stocks
3 Small-Cap Stocks Skating on Thin Ice
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
3 Consumer Stocks in Hot Water
Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. But recently, the industry has failed to do its job as it shed 9.5% over the past six months.... 
Via StockStory
Topics Stocks
Unpacking Q4 Earnings: BeautyHealth (NASDAQ:SKIN) In The Context Of Other Personal Care Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including BeautyHealth (NASDAQ:SKIN) and its peers. 
Via StockStory
Topics Economy
Q4 Earnings Highs And Lows: Coty (NYSE:COTY) Vs The Rest Of The Personal Care Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Coty (NYSE:COTY) and its peers. 
Via StockStory
Topics Economy
Nature's Sunshine (NASDAQ:NATR) Beats Q4 Sales Targets
Wellness products company Nature’s Sunshine (NASDAQ:NATR) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 8.5% year on year to $118.2 million. The company expects... 
Via StockStory
Earnings Scheduled For March 11, 2025
 
Via Benzinga
Earnings To Watch: Nature's Sunshine (NATR) Reports Q4 Results Tomorrow
Wellness products company Nature’s Sunshine (NASDAQ:NATR) will be reporting earnings tomorrow after market hours. Here’s what you need to know. 
Via StockStory
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.